Published in Osteoporos Int on June 30, 2016
Non-participation in systematic screening for osteoporosis-the ROSE trial. Osteoporos Int (2017) 0.75
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int (1994) 5.72
Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med (2011) 5.46
Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int (2014) 5.17
Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med (2002) 2.98
Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA (2007) 2.81
The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res (2014) 2.52
Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47
Alcohol intake as a risk factor for fracture. Osteoporos Int (2004) 2.34
Determinants of bone density in normal women: risk factors for future osteoporosis? BMJ (1989) 2.07
A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int (2001) 1.75
The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J (2007) 1.51
Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures. Health Aff (Millwood) (2011) 1.37
Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med (1995) 1.35
Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Am J Med (1997) 1.34
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes. J Bone Miner Res (2012) 1.27
Ten-year risk of osteoporotic fractures in postmenopausal Chinese women according to clinical risk factors and BMD T-scores: a prospective study. J Bone Miner Res (2007) 1.24
The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States. Osteoporos Int (2008) 1.11
Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study. J Gen Intern Med (2015) 1.07
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract (2006) 1.07
Medicare program; Medicare coverage of and payment for bone mass measurements--HCFA. Interim final rule with comment period. Fed Regist (1998) 1.06
Summary of the International Society For Clinical Densitometry 2005 Position Development Conference. J Bone Miner Res (2007) 0.89
DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women. J Clin Densitom (2015) 0.80